Literature DB >> 33407701

Bone fragility in patients affected by congenital diseases non skeletal in origin.

L Masi1, S Ferrari2, M K Javaid3, S Papapoulos4, D D Pierroz5, M L Brandi6,7.   

Abstract

BACKGROUND: Bone tissue represents a large systemic compartment of the human body, with an active metabolism, that controls mineral deposition and removal, and where several factors may play a role. For these reasons, several non-skeletal diseases may influence bone metabolism. It is of a crucial importance to classify these disorders in order to facilitate diagnosis and clinical management. This article reports a taxonomic classification of non-skeletal rare congenital disorders, which have an impact on bone metabolism
METHODS: The International Osteoporosis Foundation (IOF) Skeletal Rare Diseases Working Group (SRD-WG), comprised of basic and clinical scientists, has decided to review the taxonomy of non-skeletal rare disorders that may alter bone physiology.
RESULTS: The taxonomy of non-skeletal rare congenital disorders which impact bone comprises a total of 6 groups of disorders that may influence the activity of bone cells or the characteristics of bone matrix.
CONCLUSIONS: This paper provides the first comprehensive taxonomy of non-skeletal rare congenital disorders with impact on bone physiology.

Entities:  

Keywords:  Bone metabolism; Genetic bone diseases; Metabolic bone diseases; Non-skeletal rare congenital disorders; Taxonomy

Mesh:

Year:  2021        PMID: 33407701      PMCID: PMC7789665          DOI: 10.1186/s13023-020-01611-5

Source DB:  PubMed          Journal:  Orphanet J Rare Dis        ISSN: 1750-1172            Impact factor:   4.123


  128 in total

1.  Growth hormone secretion and bone histomorphometric study in thalassaemic patients with acquired skeletal dysplasia secondary to desferrioxamine.

Authors:  V De Sanctis; S Stea; L Savarino; V Scialpi; G C Traina; G M Chiarelli; M Sprocati; R Govoni; D Pezzoli; R Gamberini; F Rigolin
Journal:  J Pediatr Endocrinol Metab       Date:  1998       Impact factor: 1.634

2.  Alkaptonuria: a 60-yr follow-up.

Authors:  R W E Watts; R A Watts
Journal:  Rheumatology (Oxford)       Date:  2006-11-20       Impact factor: 7.580

Review 3.  Function and regulation of human copper-transporting ATPases.

Authors:  Svetlana Lutsenko; Natalie L Barnes; Mee Y Bartee; Oleg Y Dmitriev
Journal:  Physiol Rev       Date:  2007-07       Impact factor: 37.312

Review 4.  Cystic fibrosis.

Authors:  Jane C Davies; Eric W F W Alton; Andrew Bush
Journal:  BMJ       Date:  2007-12-15

5.  Long-term prophylaxis in severe haemophilia seems to preserve bone mineral density.

Authors:  M Khawaji; K Akesson; E Berntorp
Journal:  Haemophilia       Date:  2008-11-03       Impact factor: 4.287

Review 6.  Lung transplantation for cystic fibrosis: an update and practical considerations for referring candidates.

Authors:  B J Shapiro; S Veeraraghavan; R G Barbers
Journal:  Curr Opin Pulm Med       Date:  1999-11       Impact factor: 3.155

7.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

8.  Bone metabolism in ochronotic patients.

Authors:  G Aliberti; I Pulignano; A Schiappoli; S Minisola; E Romagnoli; M Proietta
Journal:  J Intern Med       Date:  2003-09       Impact factor: 8.989

9.  Functional expression of cystic fibrosis transmembrane conductance regulator in mouse chondrocytes.

Authors:  Haitao Liang; Lin Yang; Tonghui Ma; Yong Zhao
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-10-16       Impact factor: 2.557

Review 10.  Gaucher disease and bone manifestations.

Authors:  Gemma Marcucci; Ari Zimran; Bruno Bembi; John Kanis; Jean-Yves Reginster; Renè Rizzoli; Cyrus Cooper; Maria Luisa Brandi
Journal:  Calcif Tissue Int       Date:  2014-11-07       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.